saxagliptin - Globe Thesis

Keyword [saxagliptin] Result: 1 - 20 \| Page: 1 of 2
1.	Saxagliptin Versus Placebo In Treatment Of Type2Diabetes In The Combination Therapy A Systematic
2.	The Efficacy Of Saxagliptin Combined With Insulin In The Treatment Of Type2Diabetes Mellitus
3.	The Effect Of Saxagliptin Monotheragy On Treating New Type2Diabetes
4.	Efficacy And Safety Of Exenatide Versus Saxagliptin Combined With Metformin In Patients With Type2Diabetes Mellitus
5.	Synthesis Of The Intermediate Of Anti-Diabetic Drug Saxagliptin
6.	Effect Of Saxagliptin On The Intestinal Flora And The Chronic Inflammation Status In Patients With Type2Diabetes Mellitus
7.	Xiao Ke Zhi Ping And Saxagliptin Used In Type2Diabetes Mellitus(qi Yin Hang Xu Jia Xue Yu Zheng)by Cross-over Design
8.	Part1:Effect Of Saxagliptin On Pre-Diabetes Mellitus And Obesity Part2:Lipodystrophy Case Report And Literature Review
9.	Clinical Observation Of DPP-4 Inhibitors In The Treatment Of T2DM
10.	Effects Of Glucagon-like Peptide-1 On Macrovascular Of Type2 Diabetic Rats
11.	The Mechanism Of Saxagliptin Protect Islets Function In Diabetic Rats Via Inhibit SDF-1α Degretion
12.	Effects Of Puerarin Combined With Saxagliptin On Blood Glucose And Renal Fibrosis In Diabetic Rats, And On Mesangial Cell Proliferation Induced By High Glucose
13.	Comparison The Efficacy Of Liraglutide、Saxagliptin And Insulin Detemir In Treatment Of Type 2 Diabetes Mellitus Inadequately Controlled
14.	Effects Of Saxagliptin On The Function Of Hypothalamus-pituitary-adrenal Axis In Patients Suffered From Type 2 Diabetes Mellitus
15.	CUMS-induced Depression Alter The Saxagliptin Pharmacokinetics And CYP450 Activity In GK Rats
16.	The Correlation Study Of Efficacy Of Exenatide Or Saxagliptin In Type 2 Diabetes And Plasma GC?Chinese Medicine Body Constitution
17.	Saxagliptin Improves Urinary Albumin/Creatinine Ratio In Patients With Type 2 Diabetes Mellitus By Targeting The NLrp3/ASC Inflammasome
18.	Efficacy And Safety Of Saxagliptin Plus Insulin In The Treatment Of Type 2 Diabetes:A Meta-analysis
19.	Glucagon-like Peptide-1 Ameliorates Cardiac Lipotoxicity In Diabetic Cardiomyopathy Via PPAR? Pathway
20.	Study On The Mechanism Of Saxagliptin In Inhibiting Podocyte Epithelial-to-mesenchymal Transition In Type 2 Diabetic Rats Via SDF-1?
<<First <Prev Next> Last>> Jump to